Herbalife (HLF) Estimates Trimmed at Pivotal Research on FX; Analyst Maintains Buy Rating
Tweet Send to a Friend
Pivotal Research earlier reiterated a Buy rating on Herbalife (NYSE: HLF) with a price target of $75. Analyst Timothy S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
